🤔 What are the new frontiers in #TechBio? How do we see the intersection of biology and tech evolving?
This Wednesday was the launch of a new HTBC TechBio chapter led by Leigh Brody, AlbionVC life sciences investor. TechBio Club is a breakfast session that welcomes founders, operators, and investors for a quarterly deepdive on the state of the TechBio ecosystem.
Thank you to our stellar first panel:
Javier Nunez-Vicandi, Sofinnova Partners,
Paul Ashley, Johnson & Johnson,
Ian McKay, Innovate UK
Leigh Brody, AlbionVC (Moderator)
Key take-aways from the discussion include:
🖖 There remains a gap in the investment landscape - techbio companies require investors with understanding both tech and bio
👨💻 The growth of techbio has been in part thanks to AI within the life science sector, but challenges around genetic data, regulatory hurdles, ethical considerations and incorporation into clinical practice are just a few of the hurdles
🌍 It's expected that there will be a streamlining of aids targeting 'low-hanging' problems soon, highlighting the dynamic nature of the field and the ongoing quest for innovation
Many thanks to HSBC Innovation Banking for hosting this quarter's session at their offices and supporting this event.
If you are operating in the space and would like to join the next session, register your interest here: https://lnkd.in/e_bW72gw
#healthcare #techbio #digitalhealth #deeptech #lifesciences #ai #drugdiscovery #vc #founders #operators #experts #investors #venturecapital #community